| A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline glioma S Pal, JP Kaplan, H Nguyen, SA Stopka, MR Savani, MS Regan, ... Cancer Cell 40 (9), 957-972. e10, 2022 | 41 | 2022 |
| A non-dividing cell population with high pyruvate dehydrogenase kinase activity regulates metabolic heterogeneity and tumorigenesis in the intestine C Sebastian, C Ferrer, M Serra, JE Choi, N Ducano, A Mira, MS Shah, ... Nature Communications 13 (1), 1503, 2022 | 24 | 2022 |
| The methyltransferases METTL7A and METTL7B confer resistance to thiol-based histone deacetylase inhibitors RW Robey, CM Fitzsimmons, WM Guiblet, WJE Frye, ... Molecular Cancer Therapeutics 23 (4), 464-477, 2024 | 3 | 2024 |
| The thiol methyltransferase activity of TMT1A (METTL7A) is conserved across species JMG Dalmasy, CM Fitzsimmons, WJE Frye, AJ Perciaccante, CP Jewell, ... Chemico-Biological Interactions 394, 110989, 2024 | | 2024 |
| Abstract B038: Preclinical efficacy of KRASG12C inhibitors in models of pediatric cancer H Price, S Stauffer, K Powell, A Baker, A Perciaccante, ER Hernandez, ... Molecular Cancer Research 21 (5_Supplement), B038-B038, 2023 | | 2023 |
